Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 145

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 145
---
 the Divestiture Agreement have not been satisfied; 
 (3) prior to the termination of the Divestiture Agreement, an acquisition proposal to engage in an Acquisition Transaction (as defined in the Divestiture Agreement) (except that all references to “15%” in the definition of Acquisition  
 Transaction in the Divestiture Agreement will be deemed to be references to “50%”) is received from any person other than Kaken or any of its affiliates has been publicly announced or publicly disclosed and not withdrawn or otherwise   
 abandoned at within a certain period prior to the termination of the Divestiture Agreement; and (4) within one year of the termination of the Divestiture Agreement, either an Acquisition Transaction (except that all references to       
 “15%” in the definition of Acquisition Transaction in the Divestiture Agreement will be deemed to be references to “50%”) is consummated, or Aadi or Aadi Sub enter into a definitive agreement providing for the consummation of           
 such a transaction and it is subsequently completed;                                                                                                                                                                                        |

- 93 -

| • |     | the Divestiture Agreement is terminated by Kaken after Aadi’s board of directors changes its recommendation 
 with respect to the Divestiture;                                                                            |

| • |     | the Divestiture Agreement is terminated by Aadi, prior to the approval of the Divestiture Agreement and the                                                                                                                              
 Divestiture by the requisite affirmative vote of Aadi stockholders, if (1) Aadi has received a Superior Proposal; (2) Aadi’s board of directors has authorized Aadi to enter into an Alternative Acquisition Agreement to consummate the 
 acquisition transaction contemplated by such Superior Proposal; and (3) Aadi has complied in all material respects with its obligations under the Superior Proposal provisions in the Divestiture Agreement; or                          |

| • |     | (1) the Divestiture Agreement is terminated by either Kaken or Aadi, and (2) prior to such termination, at                                                                                                                                            
 the Special Meeting at which a vote is taken on the approval of the Divestiture Agreement, the Divestiture and the other transactions set forth in this proxy statement, Aadi stockholders have failed to approve the other transactions set forth in 
 this proxy statement.                                                                                                                                                                                                                                 |

The Divestiture Agreement also provides that Aadi, on the one hand, or Kaken, on the other hand, may specifically enforce the obligations under the Divestiture Agreement, except that a party may only cause the other